$10.03
0.010.10%
At close: Dec 17, 4:00 PM EST
$10.07
0.040.40%
After Hours: Dec 8, 8:54 AM EST
Comments
Loading...
Latest LightWave Acquisition Stock News | NASDAQ:LWAC | Benzinga
Get the latest news on LightWave Acquisition stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on LightWave Acquisition performance
Categories: All
Wednesday, June 25, 2025
Thursday, August 26, 2021
Wednesday, August 25, 2021
- Mid-Afternoon Market Update: Dow Rises 100 Points; ScanSource Shares Surge Following Q4 Results
- Mid-Day Market Update: Gold Down 1%; Locust Walk Acquisition Shares Jump
- 36 Stocks Moving In Wednesday's Mid-Day Session
- Mid-Morning Market Update: Markets Edge Higher; Dick's Sporting Goods Beats Q2 Views
- Locust Walk Acquisition Shares Resume Trade, ...
- Stocks That Hit 52-Week Highs On Wednesday
- Locust Walk Acquisition Shares Halted On Circ...
- Locust Walk Acquisition Shares Resume Trade, ...
- Locust Walk Acquisition Corp Shares Halted On...
- Locust Walk Acquisition Corp. Shares Resume T...
- Locust Walk Acquisition Corp. Shares Halted O...
- Why Is This SPAC Surging 160% Today?
- Locust Walk Acquisition shares are trading hi...
- 21 Stocks Moving in Wednesday's Pre-Market Session
- Locust Walk Acquisition Shares Trade as High ...
Tuesday, August 24, 2021
Monday, August 23, 2021
Thursday, July 22, 2021
Wednesday, June 23, 2021
- EXCLUSIVE: eFFECTOR, Locust Walk Acquisition CEOs On SPAC Deal, Drug Pipeline
- Exclusive: Locust Walk Acquisition CEO, Chris Ehrlich & CEO Of eFFECTOR, Steve Worland Now Interviewing On Benzinga's SPACs Attack Show
- Exclusive: Locust Walk Acquisition CEO, Chris...
- Benzinga Pro's Top 5 Stocks To Watch For Wedn...
Tuesday, June 22, 2021
Tuesday, June 01, 2021
Thursday, May 27, 2021
- Benzinga Pro's Top 5 Stocks To Watch For Thur...
- Locust Walk Acquisition Shares Resume Trading...
- Locust Walk Acquisition Shares Set To Resume ...
- Locust Walk Acquisition Shares Halted On Code...
- EXCLUSIVE: eFFECTOR Therapeutics Announces SPAC Deal To Advance Cancer-Fighting Pipeline
- eFFECTOR Therapeutics, Locust Walk Acquisitio...
